Company Filing History:
Years Active: 2001-2002
Title: Katalin Horváth: Innovator in Medicinal Chemistry
Introduction
Katalin Horváth is a prominent inventor based in Budapest, Hungary. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the central nervous system. With a total of five patents to her name, her work has the potential to impact the treatment of various neurological diseases.
Latest Patents
Among her latest patents are innovative compounds known as 2,3-benzodiazepine derivatives. These compounds are designed to act as AMPA-receptor inhibitors. The invention concerns compounds of formula (I), where R, R, R, and R can represent hydrogen or various substituents. The variable X can denote hydrogen or halogen, while Y may indicate C1-alkoxy or a combination of X and Y that forms a specific structure. The compounds are notable for their non-competitive inhibition of AMPA receptors, making them promising candidates for medicaments aimed at treating central nervous system disorders.
Career Highlights
Katalin has worked with notable organizations such as Gyógyszerkutató Intézet Kft. and Schering Aktiengesellschaft. Her experience in these companies has allowed her to refine her expertise in drug development and medicinal chemistry.
Collaborations
Throughout her career, Katalin has collaborated with esteemed colleagues, including Antal Simay and István Ling. These partnerships have contributed to her innovative research and the advancement of her patented technologies.
Conclusion
Katalin Horváth's work in the field of medicinal chemistry exemplifies the impact of innovative research on healthcare. Her contributions, particularly in the development of AMPA-receptor inhibitors, hold promise for future treatments of neurological diseases.